Inhibition of Phosphatidylinositol 3-Kinase Increases Efficacy of Cisplatin in in Vivo Ovarian Cancer Models

Tsuyoshi Ohta(Yamagata University), Hirohisa Kurachi(Osaka Women's and Children's Hospital), Maki Saitoh(Yamagata University), Keiichi Tasaka(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Masakazu Doshida(Yamagata University), Hideki Igarashi(Yamagata University), Seiji Mabuchi(The University of Osaka), Kazuhiro Takahashi, Jun Kawagoe, Teiichi Motoyama(Yamagata University), Botao Du(Yamagata University), Tadashi Hayasaka, Masahide Ohmichi(Osaka University of Pharmaceutical Sciences), Ishida Gabriela Mirei(Yamagata University)
Endocrinology
January 6, 2006
10.1210/en.2005-1450
Cited by 92

Related Papers

Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
|PubMed|2000|249
Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells
|Molecular Cancer Research|2016|232
A Physiological Role of Epidermal Growth Factor in Male Reproductive Function
|Science|1986|222
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212